145 related articles for article (PubMed ID: 23929638)
1. Changes in Farr radioimmunoassay and EliA fluorescence immunoassay anti-dsDNA in relation to exacerbation of SLE.
Hillebrand JJ; Bernelot Moens HJ; Mulder AH
Lupus; 2013 Oct; 22(11):1169-73. PubMed ID: 23929638
[TBL] [Abstract][Full Text] [Related]
2. Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease.
de Leeuw K; Bungener L; Roozendaal C; Bootsma H; Stegeman CA
Rheumatology (Oxford); 2017 May; 56(5):698-703. PubMed ID: 28053277
[TBL] [Abstract][Full Text] [Related]
3. Clinical disease activity and titers of anti-dsDNA antibodies measured by an automated immunofluorescence assay in patients with systemic lupus erythematosus.
López-Hoyos M; Cabeza R; Martínez-Taboada VM; Crespo J; SanSegundo D; Blanco R; López-Escribano H; Peña M; Rodríguez-Valverde V
Lupus; 2005; 14(7):505-9. PubMed ID: 16130504
[TBL] [Abstract][Full Text] [Related]
4. Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test.
Antico A; Platzgummer S; Bassetti D; Bizzaro N; Tozzoli R; Villalta D;
Lupus; 2010 Jul; 19(8):906-12. PubMed ID: 20179169
[TBL] [Abstract][Full Text] [Related]
5. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study.
ter Borg EJ; Horst G; Hummel EJ; Limburg PC; Kallenberg CG
Arthritis Rheum; 1990 May; 33(5):634-43. PubMed ID: 2346519
[TBL] [Abstract][Full Text] [Related]
6. Changes in levels of antibodies against the 70 kDa and a polypeptides of the U1RNP complex in relation to exacerbations of systemic lupus erythematosus.
ter Borg EJ; Horst G; Limburg PC; van Venrooij WJ; Kallenberg CG
J Rheumatol; 1991 Mar; 18(3):363-7. PubMed ID: 1830337
[TBL] [Abstract][Full Text] [Related]
7. [Capacity to predict a recurrence of lupus erythematosus using double-stranded anti-DNA antibodies and Farr technique].
Massardo L; Martínez ME; Pérez R; Ramírez V; Foradori A; González A; Radrigán F; Gutiérrez F; Jacobelli S
Rev Med Chil; 1999 Apr; 127(4):411-20. PubMed ID: 10451606
[TBL] [Abstract][Full Text] [Related]
8. A comparison between the Farr radioimmunoassay and a new automated fluorescence immunoassay for the detection of antibodies against double stranded DNA in serum.
Derksen RH; Bast EJ; Strooisma T; Jacobs JW
Ann Rheum Dis; 2002 Dec; 61(12):1099-102. PubMed ID: 12429543
[TBL] [Abstract][Full Text] [Related]
9. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
[TBL] [Abstract][Full Text] [Related]
10. Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with the standard ELISA.
Yu L; Wang J; O'Dell JR; Oates J; Arend WP; Eisenbarth GS
J Rheumatol; 2007 Apr; 34(4):734-9. PubMed ID: 17407230
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of a new automated anti-dsDNA fluorescent immunoassay.
Hernando M; González C; Sánchez A; Guevara P; Navajo JA; Papisch W; González-Buitrago JM
Clin Chem Lab Med; 2002 Oct; 40(10):1056-60. PubMed ID: 12476949
[TBL] [Abstract][Full Text] [Related]
12. Anti-dsDNA antibody testing by Farr and ELISA techniques is not equivalent.
Neogi T; Gladman DD; Ibanez D; Urowitz M
J Rheumatol; 2006 Sep; 33(9):1785-8. PubMed ID: 16924691
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Farr radioimmunoassay, 3 commercial enzyme immunoassays and Crithidia luciliae immunofluorescence test for diagnosis and activity assessment of systemic lupus erythematosus.
Launay D; Schmidt J; Lepers S; Mirault T; Lambert M; Kyndt X; Reumaux D; Duhamel A; Hachulla E; Hatron PY; Prin L; Dubucquoi S
Clin Chim Acta; 2010 Jul; 411(13-14):959-64. PubMed ID: 20303931
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of ELISA positive and immunofluorescence negative anti-dsDNA antibody.
Kim KH; Han JY; Kim JM; Lee SW; Chung WT
Clin Chim Acta; 2007 May; 380(1-2):182-5. PubMed ID: 17355877
[TBL] [Abstract][Full Text] [Related]
15. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
16. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.
Mok CC; Ho LY; Leung HW; Wong LG
Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493
[TBL] [Abstract][Full Text] [Related]
17. Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?
Riboldi P; Gerosa M; Moroni G; Radice A; Allegri F; Sinico A; Tincani A; Meroni PL
Autoimmunity; 2005 Feb; 38(1):39-45. PubMed ID: 15804704
[TBL] [Abstract][Full Text] [Related]
18. A fluorescence sedimentation assay for dsDNA antibodies.
Duus K; Draborg AH; Güven E; Moreno YM; Jacobsen S; Nielsen CT; Houen G
Scand J Clin Lab Invest; 2017 Oct; 77(6):465-471. PubMed ID: 28678535
[TBL] [Abstract][Full Text] [Related]
19. Comparison of three anti-dsDNA assays: performance and correlation with systemic lupus erythematosus disease activity.
Venner AA; Ibañez D; Gladman DD; Urowitz MB; MacKinnon A; Blasutig IM; Yip PM
Clin Biochem; 2013 Mar; 46(4-5):317-20. PubMed ID: 23246539
[TBL] [Abstract][Full Text] [Related]
20. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.
Saigal R; Goyal LK; Agrawal A; Mehta A; Mittal P; Yadav RN; Meena PD; Wadhvani D
J Assoc Physicians India; 2013 Jun; 61(6):372-7. PubMed ID: 24640201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
